Upregulation of miR-125b by estrogen protects against non-alcoholic fatty liver in female mice

Journal of Hepatology

Volumn 63, Issue 6, 2015, Pages 1466-1475

  Zhang, Zhi Chun ^a   Liu, Yan ^a   Xiao, Liu Ling ^a   Li, Shu Fen ^a   Jiang, Jing Hui ^a   Zhao, Yue ^a   Qian, Shu Wen ^a   Tang, Qi Qun ^a,b   Li, Xi ^a  

^a FUDAN UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

Estrogen; FAS; Lipogenesis; miR 125b; NAFLD; Premenopause

Indexed keywords

ESTROGEN; ESTROGEN RECEPTOR ALPHA; MICRORNA 125B; TRIACYLGLYCEROL; FATTY ACID SYNTHASE; MICRORNA; MIRN125 MICRORNA, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; FATTY ACID TRANSPORT; FEMALE; GENE EXPRESSION; HEPG2 CELL LINE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LIPID DIET; LIPID STORAGE; LIPOGENESIS; LIVER PROTECTION; MALE; MOUSE; NONALCOHOLIC FATTY LIVER; NONHUMAN; PRIORITY JOURNAL; UPREGULATION; ADVERSE EFFECTS; ANIMAL; ANTAGONISTS AND INHIBITORS; C57BL MOUSE; GENE EXPRESSION REGULATION; GENE SILENCING; GENETICS; LIPID METABOLISM; LIVER; METABOLISM; NON-ALCOHOLIC FATTY LIVER DISEASE; OVARIECTOMY; PATHOLOGY;

ANIMALS; DIET, HIGH-FAT; ESTROGEN RECEPTOR ALPHA; ESTROGENS; FATTY ACID SYNTHASES; FEMALE; GENE EXPRESSION REGULATION; GENE KNOCKDOWN TECHNIQUES; HEP G2 CELLS; HUMANS; LIPID METABOLISM; LIVER; MALE; MICE; MICE, INBRED C57BL; MICRORNAS; NON-ALCOHOLIC FATTY LIVER DISEASE; OVARIECTOMY; UP-REGULATION;

EID: 84951077822     PISSN: 01688278     EISSN: 16000641     Source Type: Journal    
DOI: 10.1016/j.jhep.2015.07.037     Document Type: Article

References (38)

1. P. Angulo Nonalcoholic fatty liver disease N Engl J Med 346 2002 1221 1231
2. N.M. De Alwis, and C.P. Day Non-alcoholic fatty liver disease: the mist gradually clears J Hepatol 48 2008 S104 S112
3. B.Q. Starley, C.J. Calcagno, and S.A. Harrison Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection Hepatology 51 2010 1820 1832
4. Q.M. Anstee, G. Targher, and C.P. Day Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis Nat Rev Gastroenterol Hepatol 10 2013 330 344
5. A. Suzuki, and M.F. Abdelmalek Nonalcoholic fatty liver disease in women Women's Health 5 2009 191 203
6. J.D. Yang, M.F. Abdelmalek, H. Pang, C.D. Guy, A.D. Smith, A.M. Diehl, and et al. Gender and menopause impact severity of fibrosis among patients with nonalcoholic steatohepatitis Hepatology 59 2014 1406 1414
7. L. Zhu, W.C. Brown, Q. Cai, A. Krust, P. Chambon, O.P. McGuinness, and et al. Estrogen treatment after ovariectomy protects against fatty liver and may improve pathway-selective insulin resistance Diabetes 62 2013 424 434
8. M.E.E. Jones, A.W. Thorburn, K.L. Britt, K.N. Hewitt, N.G. Wreford, J. Proietto, and et al. Aromatase-deficient (ArKO) mice have a phenotype of increased adiposity Proc Natl Acad Sci U S A 97 2000 12735 12740
9. M.C. Nguyen, R.B. Stewart, M.A. Banerji, D.H. Gordon, and J.G. Kral Relationships between tamoxifen use, liver fat and body fat distribution in women with breast cancer Int J Obes Relat Metab Disord 25 2001 296 298
10. L.K. Cole, R.L. Jacobs, and D.E. Vance Tamoxifen induces triacylglycerol accumulation in the mouse liver by activation of fatty acid synthesis Hepatology 52 2010 1258 1265
11. Y. Nemoto, K. Toda, M. Ono, F.A. Kiyomi, T. Saibara, S. Onishi, and et al. Altered expression of fatty acid-metabolizing enzymes in aromatase-deficient mice J Clin Invest 105 2000 1819 1825
12. C. Esau, S. Davis, S.F. Murray, X.X. Yu, S.K. Pandey, M. Pear, and et al. MiR-122 regulation of lipid metabolism revealed by in vivo antisense targeting Cell Metab 3 2006 87 98
13. A. Dávalos, L. Goedeke, P. Smibert, C.M. Ramírez, N.P. Warrier, and U. Andreo MiR-33a/b contribute to the regulation of fatty acid metabolism and insulin signaling Proc Natl Acad Sci U S A 108 2011 9232 9237
14. R. Ng, H. Wu, H. Xiao, X. Chen, H. Willenbring, C.J. Steer, and et al. Inhibition of mir-24 expression in liver prevents hepatic lipid accumulation and hyperlipidemia Hepatology 60 2014 554 564
15. F. Xiao, J. Yu, B. Liu, Y. Guo, K. Li, J. Deng, and et al. A novel function of microRNA 130a-3p in hepatic insulin sensitivity and liver steatosis Diabetes 63 2014 2631 2642
16. Y. Guan, H. Yao, Z. Zheng, G. Qiu, and K. Sun MiR-125b targets BCL3 and suppresses ovarian cancer proliferation Int J Cancer 128 2011 2274 2283
17. M.V. Iorio, M. Ferracin, C.G. Liu, A. Veronese, R. Spizzo, S. Sabbioni, and et al. MicroRNA gene expression deregulation in human breast cancer Cancer Res 65 2005 7065 7070
18. G. Alpini, S.S. Glaser, J.P. Zhang, H. Francis, Y. Han, J. Gong, and et al. Regulation of placenta growth factor by microRNA-125b in hepatocellular cancer J Hepatol 55 2011 1339 1345
19. E. Tili, J.J. Michaille, Z. Luo, S. Volinia, L.Z. Rassenti, T.J. Kipps, and et al. The down-regulation of miR-125b in chronic lymphocytic leukemias leads to metabolic adaptation of cells to a transformed state Blood 120 2012 2631 2638
20. F.X. Donadeu, S.N. Schauer, and S.D. Sontakke Involvement of miRNAs in ovarian follicular and luteal development J Endocrinol 215 2012 323 334
21. T. Mishima, T. Takizawa, S.S. Luo, O. Ishibashi, Y. Kawahigashi, Y. Mizuguchi, and et al. MicroRNA (miRNA) cloning analysis reveals sex differences in miRNA expression profiles between adult mouse testis and ovary Reproduction 136 2008 811 822
22. A.J. Murphy, P.M. Guyre, and P.A. Pioli Estradiol suppresses NF-κB activation through coordinated regulation of let-7a and miR-125b in primary human macrophages J Immunol 184 2010 5029 5037
23. S. Li, X. Chen, H. Zhang, X. Liang, Y. Xiang, C. Yu, and et al. Differential expression of microRNAs in mouse liver under aberrant energy metabolic status J Lipid Res 50 2009 1756 1765
24. S.I. Han, Y. Komatsu, A. Murayama, K.R. Steffensen, Y. Nakagawa, Y. Nakajima, and et al. Estrogen receptor ligands ameliorate fatty liver through a nonclassical estrogen receptor/Liver X receptor pathway in mice Hepatology 59 2014 1791 1802
25. A. Paquette, D. Wang, M. Jankowski, J. Gutkowska, and J.M. Lavoie Effects of ovariectomy on PPAR alpha, SREBP-1c, and SCD-1 gene expression in the rat liver Menopause 15 2008 1169 1175
26. L. Castellano, G. Giamas, J. Jacob, R.C. Coombes, W. Lucchesi, P. Thiruchelvam, and et al. The estrogen receptor-alpha-induced microRNA signature regulates itself and its transcriptional response Proc Natl Acad Sci U S A 106 2009 15732 15737
27. G. Di Leva, C. Piovan, P. Gasparini, A. Ngankeu, C. Taccioli, D. Briskin, and et al. Estrogen mediated-activation of miR-191/425 cluster modulates tumorigenicity of breast cancer cells depending on estrogen receptor status PLoS Genet 9 2013 e1003311
28. C.M. Kilnge Estrogen receptor interaction with estrogen response elements Nucleic Acids Res 29 2001 2905 2919
29. G. Bryzgalova, L. Lundholm, N. Portwood, J.A. Gustafsson, A. Khan, S. Efendic, and et al. Mechanisms of antidiabetogenic and body weight-lowering effects of estrogen in high-fat diet-fed mice Am J Physiol Endocrinol Metab 295 2008 E904 E912
30. T. Yoshizawa, M.F. Karim, Y. Sato, T. Senokuchi, K. Miyata, T. Fukuda, and et al. SIRT7 controls hepatic lipid metabolism by regulating the ubiquitin-proteasome pathway Cell Metab 19 2014 712 721
31. J.K. Kim, J.H. Noh, K.H. Jung, J.W. Eun, H.J. Bae, M.G. Kim, and et al. Sirtuin7 oncogenic potential in human hepatocellular carcinoma and its regulation by the tumor suppressors MiR-125a-5p and MiR-125b Hepatology 57 2013 1055 1067
32. Y. Han, Y. Liu, H. Zhang, T. Wang, R. Diao, Z. Jiang, and et al. Hsa-miR-125b suppresses bladder cancer development by down-regulating oncogene SIRT7 and oncogenic long non-coding RNA MALAT1 FEBS Letters 587 2013 3875 3882
33. J. Shin, M. He, Y. Liu, S. Paredes, L. Villanova, K. Brown, and et al. SIRT7 represses Myc activity to suppress ER stress and prevent fatty liver disease Cell Rep 5 2013 654 665
34. H.C. Huang, H.R. Yu, L.T. Huang, H.C. Huang, R.F. Chen, I.C. Lin, and et al. MiRNA-125b regulates TNF-α production in CD14+ neonatal monocytes via post-transcriptional regulation J Leukoc Biol 92 2012 171 182
35. E. Tili, J.J. Michaille, A. Cimino, S. Costinean, C.D. Dumitru, B. Adair, and et al. Modulation of miR-155 and miR-125b levels following lipopolysaccharide/TNF-alpha stimulation and their possible roles in regulating the response to endotoxin shock J Immunol 179 2007 5082 5089
36. E.F. Scapa, A. Pocai, M.K. Wu, R. Gutierrez-Juarez, L. Glenz, K. Kanno, and et al. Regulation of energy substrate utilization and hepatic insulin sensitivity by phosphatidylcholine transfer protein/StarD2 FASEB J 22 2008 2579 2590
37. T. Matsuzaka, H. Shimano, N. Yahagi, T. Kato, A. Atsumi, T. Yamamoto, and et al. Crucial role of a long-chain fatty acid elongase, Elovl6, in obesity-induced insulin resistance Nat Med 13 2007 1193 1202
38. L. Wang, B. Balas, C.Y. Christ-Roberts, R.Y. Kim, F.J. Ramos, C.K. Kikani, and et al. Peripheral disruption of the Grb10 gene enhances insulin signaling and sensitivity in vivo Mol Cell Biol 27 2007 6497 6505